Cancer Focus Fund invests $4.5M into Houston-based March Biosciences

The Cancer Focus Fund LP invested $4.8 million into March Biosciences, a cell therapy company that has already tapped some of Houston’s growing life sciences resources. Click through to the story to find out why a founder of the fund called it “a seminal moment in the Houston biotech and life sciences history.”